| Literature DB >> 27401362 |
Daniel K Ebner1, Megumi Ohsawa2, Keiko Igari3, Kouji H Harada2, Akio Koizumi2.
Abstract
OBJECTIVES: Kawauchi Village lies 20 km west of the Fukushima Daiichi nuclear power plant. On 16 March 2011, evacuation was ordered due to the threat of radiological exposure, and was lifted in April 2012. In this study, we aimed to evaluate the predisaster and postdisaster health status of the Kawauchi Villagers, measured by routine yearly physical examinations.Entities:
Keywords: Fukushima Daiichi Nuclear Power Plant accident; disaster; evacuation; medical health check-up; metabolic disease
Mesh:
Year: 2016 PMID: 27401362 PMCID: PMC4947762 DOI: 10.1136/bmjopen-2016-011641
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Number of participants in Kawauchi Village health checkup under the national health insurance system
| Examination year | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 |
|---|---|---|---|---|---|---|
| Population | 3192 | 3100 | 3004 | 2895 | 2801 | 2794 |
| Participants number | 777 | 797 | 779 | Disaster | 674 | 576 |
| Per cent | 24.3 | 25.7 | 25.9 | 24.1 | 20.6 | |
| In Kawauchi | 777 | 797 | 779 | − | 431 | 477 |
| Evacuated (Koriyama City) | − | − | − | − | 184 | 99 |
| Evacuated (Fukushima Prefecture) | − | − | − | − | 26 | − |
| Evacuated (elsewhere) | − | − | − | − | 33 | − |
| Age (mean±SD) | 68.6±11.0 | 68.3±11.3 | 68.0±11.2 | − | 66.7±11.7 | 68.3±10.9 |
| ANOVA p=0.016 | A* | AB* | AB* | − | B* | AB* |
| Gender (male/female) | 42%/58% | 43%/57% | 41%/59% | − | 44%/56% | 43%/57% |
| χ2 Test p=0.704 | − |
*p<0.05: Means on the same row that do not share a letter are significantly different. For example, there is no statistical difference between A and AB, while there is a significant difference between A and B.
ANOVA, analysis of variance.
Results of self-reported lifestyle-related factors assessment by using medical questionnaire
| Examined year | Percentage (%) (n) | χ2 Test | |||||
|---|---|---|---|---|---|---|---|
| Test items | Question (answer choices) | 2008 | 2009 | 2010 | 2012 | 2013 | p Value |
| Physical activity | Do you do exercise that makes you sweat for at least 30 min twice a week, and have you been doing this for at least 1 year? (Yes/No) | 35/65 (n=720) | 40/60 (n=557) | 38/62 (n=552) | 41/59 (n=511) | 42/59 (n=411) | 0.17 |
| Alcohol consumption | How often do you drink alcohol? (everyday/occasionally/rarely/never) | 21/18/18/44 (n=739) | 20/21/21/39 (n=779) | 20/20/21/39 (n=760) | 23/20/17/41 (n=649) | 19/20/20/40 (n=572) | 0.146 |
| Tobacco consumption | At present, do you have a smoking habit? (Yes/No) | 13/87 (n=745) | 14/86 (n=787) | 12/88 (n=765) | 12/88 (n=649) | 14/86 (n=574) | 0.66 |
| Sleep patterns | Do you feel you get sound sleep and get enough rest? (Yes/No) | 81/19 (n=720) | 77/23 (n=565) | 74/26 (n=555) | 69/31 (n=518) | 67/33 (n=437) | 0.0001* |
| Dietary habits | Skip breakfast 3 times a week (Yes/No) | 6/94 (n=719) | 7/93 (n=561) | 5/95 (n=553) | 6/94 (n=519) | 11/89 (n=437) | 0.0143* |
| Take additional foods after dinner 3 times a week (Yes/No) | 10/90 (n=721) | 14/86 (n=563) | 14/86 (n=553) | 10/90 (n=515) | 14/86 (n=438) | 0.0779 | |
| Eating dinner 2 hours before sleep 3 times a week (Yes/No) | 27/73 (n=720) | 27/73 (n=559) | 22/78 (n=551) | 22/78 (n=510) | 23/77 (n=435) | 0.035* | |
| Medications | Antihypertensive (Yes/No) | 50/50 (n=729) | 51/49 (n=768) | 49/51 (n=758) | 51/49 (n=645) | 53/47 (n=573) | 0.6009 |
| Antidyslipidaemic (Yes/No) | 18/82 (n=729) | 18/82 (n=767) | 19/81 (n=757) | 23/77 (n=642) | 26/74 (n=570) | 0.0028* | |
| Antidiabetic (Yes/No) | 8/92 (n=729) | 8/92 (n=767) | 6/94 (n=757) | 9/91 (n=644) | 9/91 (n=572) | 0.2756 | |
| Diagnosis of chronic renal failure or dialysis treatment (Yes/No) | 0.4/99.6 (n=729) | 0.3/99.7 (n=767) | 0.3/99.7 (n=757) | 0/100 (n=639) | 0.3/99.7 (n=572) | 0.4013 | |
*p<0.05.
Demographics of the total Kawauchi population
| Examined year | Mean±SD (n) Tukey's HSD test | ANOVA | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test items | 2008 | 2009 | 2010 | 2012 | 2013 | p Value | |||||
| Height | 152.2±9.8 (684) | A | 152.7±9.6 (666) | A | 153.1±9.4 (650) | AB | 154.6±9.7 (572) | B | 154.6±9.6 (488) | B | <0.0001* |
| Weight | 55.6±10.4 (684) | A | 55.8±10.5 (666) | A | 55.8±10.5 (650) | A | 58.7±11.1 (572) | B | 58.1±11.3 (488) | B | <0.0001* |
| BMI | 23.9±3.4 (684) | A | 23.9±3.5 (666) | A | 23.7±3.5 (650) | A | 24.5±3.7 (572) | B | 24.2±3.6 (488) | AB | <0.0001* |
| Waist circumference | 84.3±9.8 (381) | A | 84.5±9.5 (382) | AB | 85.7±9.1 (391) | ABC | 86.3±9.7 (390) | BC | 87.4±9.4 (296) | C | <0.0001* |
| Systolic blood pressure | 135.6±14.7 (684) | A | 133.0±17.5 (666) | B | 134.6±17.1 (650) | AB | 126.6±14.3 (572) | C | 126.2±14.8 (488) | C | <0.0001* |
| Diastolic blood pressure | 76.3±9.2 (684) | A | 75.2±9.7 (666) | AB | 75.9±10.8 (650) | AB | 74.5±9.2 (572) | B | 71.4±9.9 (488) | C | <0.0001* |
| eGFR | – | – | – | – | 72.1±13.4 (391) | A | 68.8±13.9 (615) | B | 66.0±12.8 (534) | C | <0.0001* |
| Blood glucose | 97.4±16.5 (596) | A | 96.8±18.3 (544) | A | 96.5±16.0 (556) | A | 101.0±21.4 (508) | B | 103.3±20.2 (425) | B | <0.0001* |
| HbA1c | 5.5±0.6 (676) | A | 5.5±0.7 (659) | A | 5.5±0.6 (643) | A | 5.6±0.7 (572) | A | 5.8±0.8 (488) | B | <0.0001* |
| HDL-C | 60.1±14.7 (676) | A | 59.7±14.5 (659) | A | 58.2±14.1 (643) | AB | 56.3±14.4 (572) | B | 56.7±13.5 (488) | B | <0.0001* |
| LDL-C | 114.9±26.7 (676) | AB | 113.6±26.2 (659) | A | 114.9±27.0 (643) | AB | 116.8±31.3 (572) | AB | 118.6±29.8 (488) | B | 0.033* |
| TG | 97.0±52.7 (676) | A | 92.9±60.0 (659) | A | 95.8±55.4 (643) | A | 109.3±81.0 (572) | B | 109.9±69.7 (488) | B | <0.0001* |
| AST | 25.8±8.3 (676) | – | 27.0±59.3 (659) | – | 24.1±7.6 (643) | – | 27.3±11.9 (572) | – | 25.5±9.4 (488) | – | 0.29 * |
| ALT | 19.8±9.5 (676) | AB | 19.6±17.9 (659) | AB | 18.9±9.4 (643) | A | 23.3±17.2 (572) | C | 21.5±13.9 (488) | BC | <0.0001* |
| γ-GTP | 31.0±34.6 (676) | AB | 29.9±34.3 (659) | A | 27.9±27.5 (643) | A | 37.4±53.2 (572) | C | 36.8±52.0 (488) | BC | <0.0001* |
| Blood creatinine | – | – | – | – | 0.75±0.23 (391) | – | 0.77±0.18 (615) | – | 0.78±0.18 (534) | – | 0.06* |
| Uric acid | 5.08±1.33 (380) | AB | 5.00±1.29 (382) | A | 5.00±1.33 (391) | A | 5.29±1.41 (615) | B | 5.26±1.39 (534) | B | <0.0001* |
*p<0.05: Means on the same row that do not share a letter are significantly different. For example, there is no statistical difference between A and AB, while there is a significant difference between A and B, or AB and C, etc.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; eGFR, estimated glomerular filtration rate; γ-GTP, γ-glutamyl transpeptidase; HbA1c, glycated haemoglobin; HDL-C, high-density lipoprotein cholesterol; HSD, honest significant difference; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride.
Trends in prevalence of lifestyle-related diseases
| Examined year | Prevalence of lifestyle-related diseases (95% CI) | Trend test | ||
|---|---|---|---|---|
| Test items | pre-earthquake | 2012 | 2013 | p Value |
| Metabolic syndrome | 17.0% (15.0 to 19.2) | 24.2% (21.0 to 27.7) | 25.2% (21.9 to 29.0) | <0.0001* |
| Obesity | 35.3% (32.4 to 38.3) | 39.7% (36.3 to 43.3) | 36.9% (33.4 to 40.5) | 0.344 |
| Hypertension | 65.7% (62.7 to 68.5) | 61.8% (58.2 to 65.2) | 63.7% (59.9 to 67.4) | 0.246 |
| Diabetes | 11.3% (9.6 to 13.4) | 14.7% (12.4 to 17.3) | 17.0% (14.4 to 20.0) | <0.0001* |
| Dyslipidaemia | 43.2% (40.3 to 46.1) | 53.9% (50.2 to 57.6) | 56.7% (52.8 to 60.6) | <0.0001* |
| Hyperuricaemia | 5.2% (3.9 to 6.9) | 10.0% (7.8 to 12.7) | 8.4% (6.3 to 11.3) | 0.006* |
| Chronic kidney disease | 16.1% (12.7 to 20.1) | 21.7% (18.5 to 25.3) | 26.7% (23.0 to 30.8) | <0.0001* |
*: p<0.05.
OR and 95% CIs of lifestyle-related diseases after the Great East Japan Earthquake
| Examined year | OR (95% CI) | ||
|---|---|---|---|
| Test items | 2012 vs pre-earthquake | 2013 vs pre-earthquake | 2013 vs 2012 |
| Metabolic syndrome | 1.55* (1.29 to 1.88) | 1.64* (1.35 to 2.01) | 1.06 (0.87 to 1.28) |
| Obesity | 1.21* (1.06 to 1.38) | 1.07 (0.93 to 1.24) | 0.89* (0.79 to 0.99) |
| Hypertension | 0.85* (0.75 to 0.96) | 0.92 (0.80 to 1.06) | 1.09 (0.94 to 1.25) |
| Diabetes | 1.35* (1.13 to 1.61) | 1.6* (1.32 to 1.95) | 1.19* (1.02 to 1.39) |
| Dyslipidaemia | 1.54* (1.33 to 1.78) | 1.72* (1.47 to 2.02) | 1.12 (0.95 to 1.32) |
| Hyperuricaemia | 2.03* (1.50 to 2.75) | 1.69* (1.16 to 2.45) | 0.83 (0.59 to 1.17) |
| Chronic kidney disease | 1.45* (1.09 to 1.92) | 1.91* (1.43 to 2.54) | 1.32* (1.10 to 1.57) |
*: p<0.05.